Preview Available with NeuroSky’s Brain to Computer Interface Technology at San Francisco’s Game Developers Conference

Now scheduling One-on-One Appointments

NeuroSky MindSet
NeuroSky Mindset


Mindflex Game, powered by NeuroSky

Star Wars Force Trainer
Star Wars Force Trainer
powered by NeuroSky

San Jose, Calif., February 24, 2010 – This year the star of the Game Developers Conference® (GDC) is shaping up to be Silicon Valley-based NeuroSky® Brain-Computer Interface (BCI) Technologies.

NeuroSky on CNN
Click on the image above to view a recent segment of CNN’s The Situation Room on NeuroSky

NeuroSky’s Brain to Computer Interface technology promises to revolutionize the traditional gaming paradigm, enhancing interactivity and in many instances, increasing the mental benefits of game play.

March 9th -13th, in San Francisco, GDC attendees will have a chance to experience how developers are embarking on the next revolution in gaming through brainwave integration. In addition, they will view the unveiling of NeruoSky’s new bio-command features and next generation of headset, specifically designed for gamers. NeuroSky will also be announcing a developer program, to support third party developers in creating new applications or enhancing current games.

Applications available for demonstration will be provided by a number of NeuroSky’s partners, including PlayLab, Roll7, MindGames, Lumosity, First Hill Media, InteraXon and Acclair. These games include iPhone and mobile games, serious games, casual games, educational games and neuro-marketing applications.

The Game Developers Conference® (GDC) is the world’s largest professionals-only game industry event. It is the essential forum for learning, inspiration, and networking for the creators of computer, console, handheld, mobile and online games.

Though small, last year’s NeuroSky booth was easily one of the most popular in the entire GDC conference, with consistently long lines for game demos throughout the conference and garnering significant attention from key media outlets.

NeuroSky’s BCI ThinkGear chip is most well known for its use in Mattel’s extremely successful Mindflex and Star Wars Force Trainer by Uncle Milton. Both of these toys sold out during the 2009 Christmas season. The Mattel Mindflex also received People’s Play Award, “Best Toy of the Year,” and was rated one of the top five toys for Christmas by Bloomberg.

However, the BCI technology is not limited to games. NeuroSky technology is now being incorporated into products as various as automotive, healthcare, education industries, and more. It’s obvious that, with such universal innovation, NeuroSky’s games and other applications are sure to have an impact in a variety of arenas in the coming years.

http://www.neurosky.com

To view NeuroSky's Electronic Press Kit, please click here.

Personal press technology previews and interviews are available.  To register for a GDC Press Pass, go to http://www.gdconf.com/aboutgdc/media.html#pr.

For all media inquiries, or to schedule a twenty minute time slot for an interview with one of NeuroSky’s staff members at the Conference, please contact:
Erika Maya
Erika@Ballantinespr.com
310 454 3080
http://www.ballantinespr.com

About NeuroSky
NeuroSky, Inc. is the leader in Brain-Computer Interface technologies for consumer product application. Founded in 2004 and headquartered in San Jose, CA, NeuroSky works with industry partners, developers, and with academic and research institutions, to provide innovative products and solutions across a wide range of areas. NeuroSky currently distributes the NeuroSky MindSet to USA, EU, Japan, China and Korea.

Grounded in over 60 years of medical research, NeuroSky’s technology has taken proven medical EEG (electroencephalograph) technology, and evolved it for application to the mass market by making it more user friendly and cost effective. Technological innovations include significant advancements in “noise” reduction, dry-sensor development (rather than requiring a conductive gel), evolved/substantial “cost engineering” (substantially reducing the price), and enabling the wearer to use it outside of a lab (without the assistance of a doctor).